BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36339295)

  • 1. A Placebo-Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease.
    Thijssen E; Makai-Bölöni S; van Brummelen E; den Heijer J; Yavuz Y; Doll RJ; Groeneveld GJ
    Mov Disord Clin Pract; 2022 Nov; 9(8):1074-1084. PubMed ID: 36339295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Detection and Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks.
    ZhuParris A; Thijssen E; Elzinga WO; Makai-Bölöni S; Kraaij W; Groeneveld GJ; Doll RJ
    Mov Disord; 2023 Oct; 38(10):1795-1805. PubMed ID: 37401265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of D1/D5 Partial Agonist PF-06412562 in Parkinson's Disease following Oral Administration.
    Papapetropoulos S; Liu W; Duvvuri S; Thayer K; Gray DL
    Neurodegener Dis; 2018; 18(5-6):262-269. PubMed ID: 30453303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease.
    Hauser RA; Ellenbogen A; Khanna S; Gupta S; Modi NB
    Neuropsychiatr Dis Treat; 2018; 14():839-845. PubMed ID: 29606877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson's disease: a Distal Finger Tapping test.
    Akram N; Li H; Ben-Joseph A; Budu C; Gallagher DA; Bestwick JP; Schrag A; Noyce AJ; Simonet C
    Sci Rep; 2022 Jan; 12(1):386. PubMed ID: 35013372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacodynamics of IPX066: an oral extended-release capsule formulation of carbidopa-levodopa, and immediate-release carbidopa-levodopa in patients with advanced Parkinson's disease.
    Mao Z; Hsu A; Gupta S; Modi NB
    J Clin Pharmacol; 2013 May; 53(5):523-31. PubMed ID: 23426902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study.
    Juhász A; Aschermann Z; Ács P; Janszky J; Kovács M; Makkos A; Harmat M; Tényi D; Karádi K; Komoly S; Takáts A; Tóth A; Nagy H; Klivényi P; Dibó G; Dézsi L; Zádori D; Annus Á; Vécsei L; Varannai L; Kovács N
    Parkinsonism Relat Disord; 2017 Apr; 37():79-86. PubMed ID: 28185758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Kano O; Tsuda H; Hayashi A; Arai M
    Parkinsons Dis; 2022; 2022():4216452. PubMed ID: 36081594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?
    Williams S; Zhao Z; Hafeez A; Wong DC; Relton SD; Fang H; Alty JE
    J Neurol Sci; 2020 Sep; 416():117003. PubMed ID: 32645513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease severity clustering based on tapping activity on mobile device.
    Surangsrirat D; Sri-Iesaranusorn P; Chaiyaroj A; Vateekul P; Bhidayasiri R
    Sci Rep; 2022 Feb; 12(1):3142. PubMed ID: 35210451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos.
    Lu M; Zhao Q; Poston KL; Sullivan EV; Pfefferbaum A; Shahid M; Katz M; Montaser-Kouhsari L; Schulman K; Milstein A; Niebles JC; Henderson VW; Fei-Fei L; Pohl KM; Adeli E
    Med Image Anal; 2021 Oct; 73():102179. PubMed ID: 34340101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing kinematic changes between a finger-tapping task and unconstrained finger flexion-extension task in patients with Parkinson's disease.
    Teo WP; Rodrigues JP; Mastaglia FL; Thickbroom GW
    Exp Brain Res; 2013 Jun; 227(3):323-31. PubMed ID: 23686150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinsonian Hand or Clinician's Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts.
    Williams S; Wong D; Alty JE; Relton SD
    J Parkinsons Dis; 2023; 13(4):525-536. PubMed ID: 37092233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.
    Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D
    Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Dose Pharmacokinetics and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson Disease: A Comparison With Immediate-Release Carbidopa-Levodopa and With Extended-Release Carbidopa-Levodopa Capsules.
    Modi NB; Mittur A; Rubens R; Khanna S; Gupta S
    Clin Neuropharmacol; 2019; 42(1):4-8. PubMed ID: 30520758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low-cost vision system based on the analysis of motor features for recognition and severity rating of Parkinson's Disease.
    Buongiorno D; Bortone I; Cascarano GD; Trotta GF; Brunetti A; Bevilacqua V
    BMC Med Inform Decis Mak; 2019 Dec; 19(Suppl 9):243. PubMed ID: 31830986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using AI to measure Parkinson's disease severity at home.
    Islam MS; Rahman W; Abdelkader A; Lee S; Yang PT; Purks JL; Adams JL; Schneider RB; Dorsey ER; Hoque E
    NPJ Digit Med; 2023 Aug; 6(1):156. PubMed ID: 37608206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Touchscreen-based finger tapping: Repeatability and configuration effects on tapping performance.
    Makai-Bölöni S; Thijssen E; van Brummelen EMJ; Groeneveld GJ; Doll RJ
    PLoS One; 2021; 16(12):e0260783. PubMed ID: 34874977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validated measure of rigidity in Parkinson's disease using alternating finger tapping on an engineered keyboard.
    Trager MH; Wilkins KB; Koop MM; Bronte-Stewart H
    Parkinsonism Relat Disord; 2020 Dec; 81():161-164. PubMed ID: 33157435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
    Pahwa R; Lyons KE; Hauser RA; Fahn S; Jankovic J; Pourcher E; Hsu A; O'Connell M; Kell S; Gupta S;
    Parkinsonism Relat Disord; 2014 Feb; 20(2):142-8. PubMed ID: 24055014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.